🎉 4th Anniversary Sale 20% OFF On All Reports Limited Time Offer Explore Reports → 🎉 4th Anniversary Sale • 20% OFF Explore →

There is substantial development happening within the Aesthetics Market owing to the heightened attention by dermatologists, plastic surgeons, and medical spa operators towards non-invasive rejuvenation body shaping, and prevention-oriented aesthetic therapies amongst an increasingly wider demographic. The increasing acceptance of cosmetic surgery, increase in males undergoing aesthetic procedures, and GLP-1 patients looking for body contouring procedures are some of the factors influencing the aesthetics industry worldwide.

Global Aesthetics Market valued USD 87.08 Billion in 2025 and is projected to grow to USD 169.55 Billion by 2035 at a CAGR of 6.89% during the forecast period 2026-2035. There are various factors that have been contributing towards growth within the Aesthetics Market such as increased adoption of combination therapy approaches, increasing demands for male aesthetic procedures, increase in preventive aesthetics amongst younger demographics, and rapid proliferation of medical spas across the world.

Gain Actionable Intelligence on the Aesthetics Market - Request a Sample Report

Aesthetics market

Key Players

Some of the major companies operating in the Aesthetics Market are AbbVie Inc. (Allergan Aesthetics), Galderma S.A., Merz Pharmaceuticals GmbH, Revance Therapeutics, Inc., InMode Ltd., Hologic, Inc. (Cynosure), Cutera, Inc., BTL Industries, Solta Medical (Bausch Health), Medytox Inc., Hugel Inc., Teoxane SA, Evolus Inc., and others.

Strategic Developments & Industry Innovations

  • Allergan Aesthetics (AbbVie) opened three new Allergan Medical Institute training centers in 2025 in Irvine, Atlanta, and Austin, expanding its U.S. practitioner training infrastructure.

  • Galderma expanded its Restylane filler portfolio in 2025 with new NASHA and OBT formulations designed to deliver improved longevity and natural facial injectables.

  • Revance Therapeutics continued the commercial rollout of Daxxify across U.S. aesthetic practices in 2025, marketing its extended duration advantage over standard neuromodulators.

Top Players Driving Innovation in the Aesthetics Market:

1. AbbVie Inc.: Leading Injectable and Practitioner Training Innovation

Abbive

The Allergan Aesthetics company under AbbVie is one of the most significant players in the world aesthetics industry with its Botox and Juvederm product lines backed up by extensive training programs for practitioners.

With its new Allergan Medical Institute facilities and specifically targeted at males marketing efforts, the company strives to create brand loyalty with the next generation of injectors.

2. Galderma S.A.: Advancing Premium Dermal Filler Technology

Galderma

The injectable market dominance of Galderma is being maintained due to its Restylane range of products, which utilizes advanced technology such as NASHA and OBT technology, which help improve lift capacities and provide natural results.

The emphasis of Galderma on premium filler products caters to the rising demand from patients who desire long-lasting results.

3. Revance Therapeutics, Inc.: Extending Neuromodulator Treatment Duration

Revance

Revance is working to gain traction with their Daxxify drug throughout the United States’ aesthetic clinics by providing an approximately six-month advantage over the usual three-month drugs that act as neuromodulators.

The company is further educating the practitioners through educational sessions regarding the correct technique for administering the drug to patients.

Advancing Aesthetic Innovation Through Technology and Accessibility

The market for Aesthetics is expected to experience stable growth due to the use of multi-treatment protocols, artificial intelligence-based treatment plans, and an increase in medical spa infrastructure among practitioners across the globe. Growth in the market is expected to be facilitated by developments in body contouring equipment, male aesthetics positioning, and treatment following GLP-1 weight loss.

Key players in the market include AbbVie Inc., Galderma S.A., and Revance Therapeutics, Inc. They have been driving innovation in the industry through advanced injectable technologies, practitioner training programs, and AI-powered patient consultation tools. With consumers becoming more concerned about natural-looking outcomes and treatment accessibility, the aesthetics market will continue to play an essential part in the global wellness and self-care economy.

Parry Kardani

Parry Kardani is an experienced Research Analyst specializing in market research, business intelligence, and strategic industry analysis within the Healthcare sector. She possesses strong expertise in evaluating healthcare technologies, medical devices, diagnostics, pharmaceuticals, biotechnology, digital health solutions, healthcare IT, and emerging therapeutic innovations across global markets. Her core competencies include market sizing and forecasting, competitive benchmarking, value chain and supply chain analysis, regulatory and reimbursement assessment, technology evaluation, demand-supply analysis, and healthcare industry trend monitoring. With a strong analytical approach and deep understanding of healthcare market dynamics, she supports organizations in identifying growth opportunities, assessing competitive landscapes, and making informed strategic decisions in the rapidly evolving healthcare ecosystem.